Wharton’s Katy Milkman shares the lessons learned from last year’s Philly Vax Sweepstakes, a Penn-funded project designed to evaluate ways of increasing COVID-19 vaccinations in the city.
To commemorate Rare Disease Day, Magnolia Wang organized a lighting of the Pavilion of the Hospital of the University of Pennsylvania in support of the National Organization for Rare Disorders.
Lighting the way for rare disease
After finding out about STAC3, a rare disease without a cure, biology major Magnolia Wang of the College of Arts and Sciences set out to raise awareness and advocate for those struggling with the illness.
Match Day 2022: Persevering through the pandemic to become physicians
On March 18, 160 graduating Perelman School of Medicine students celebrated Match Day at the Jordan Medical Education Center, along with their peers, friends, and family members.
Today, Weissman and colleagues are working to develop a pan-coronavirus vaccine capable of protecting the population against SARS, MERS, SARS-CoV-2, and more. At BioNTech, Karikó is overseeing parallel but distinct research on a range of diseases in which patients receive mRNA encoding therapeutic proteins. (Image: Peggy Peterson)
From foundational discoveries to profound impact
How decades of mRNA research at Penn made powerful new COVID-19 vaccines possible—and opened a new vista for future discoveries.
The opening of the Pavilion marks the completion of the University’s largest capital building project, and culmination of a planning and design process years in the making. (Image: Eric Sucar)
nocred
Historic move ushers in new era of care
Over eight hours, 310 patients moved to the Pavilion, a 17-story, 1.5-million-square-foot addition to the Hospital of the University of Pennsylvania campus.
A creative rendition of SARS-CoV-2 virus particles, not to scale. As of mid-July, the virus has sickened more than 186 million people worldwide and more than 4 million people have died from it, according to the World Health Organization. Globally, more than 3.3 billion vaccine doses have been administered. (Homepage image: NIAID)
The long view on COVID-19 vaccine safety and efficacy
Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines.
Today, Weissman and colleagues are working to develop a pan-coronavirus vaccine capable of protecting the population against SARS, MERS, SARS-CoV-2, and more. At BioNTech, Karikó is overseeing parallel but distinct research on a range of diseases in which patients receive mRNA encoding therapeutic proteins. (Image: Peggy Peterson)
